Citation Impact
Citing Papers
Inhibitors of TLR8 Reduce TNF Production from Human Rheumatoid Synovial Membrane Cultures
2008
An internet survey of 2,596 people with fibromyalgia
2007 Standout
The Hawthorne Effect: a randomised, controlled trial
2007 Standout
Psychological therapies for the management of chronic pain (excluding headache) in adults
2012 Standout
Non-steroidal anti-inflammatory drugs for low back pain
2008
Bioorthogonal Chemistry: Fishing for Selectivity in a Sea of Functionality
2009 StandoutNobel
Effectiveness of Dry Needling for Upper-Quarter Myofascial Pain: A Systematic Review and Meta-analysis
2013 Standout
OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines
2008 Standout
The Placebo Effect: Dissolving the Expectancy Versus Conditioning Debate.
2004 Standout
The effect of the 5‐HT3 receptor antagonist, alosetron, on brain responses to visceral stimulation in irritable bowel syndrome patients
2002
Intraarticular corticosteroid for treatment of osteoarthritis of the knee
2005
OARSI guidelines for the non-surgical management of knee osteoarthritis
2014 Standout
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
The OA Trial Bank: meta-analysis of individual patient data from knee and hip osteoarthritis trials show that patients with severe pain exhibit greater benefit from intra-articular glucocorticoids
2016
Mechanical, thermal and formalin-induced nociception is differentially altered in 5-HT1A−/−, 5-HT1B−/−, 5-HT2A−/−, 5-HT3A−/− and 5-HTT−/− knock-out male mice
2007 StandoutNobel
Non-specific low back pain
2016 Standout
Is serotonin hyperalgesic or analgesic?
2006
Management of Fibromyalgia Syndrome
2004
Transient receptor potential channels: targeting pain at the source
2008 StandoutNobel
Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians
2017 Standout
The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials
2008 Standout
Pharmacological FMRI in the development of new analgesic compounds
2006
The Serotonin Signaling System: From Basic Understanding To Drug Development for Functional GI Disorders
2007 Standout
A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia
2002
The treatment of chronic fatigue syndrome: Science and speculation
1994
Neuroimaging of the Brain-Gut Axis: From Basic Understanding to Treatment of Functional GI Disorders
2006
Sensors of the innate immune system: their link to rheumatic diseases
2010 StandoutNobel
Intraarticular corticosteroid for treatment of osteoarthritis of the knee
2006
The Frequency of Transition of Chronic Low Back Pain to Fibromyalgia
1995
Calcitonin Gene–Related Peptide Receptor Antagonist BIBN 4096 BS for the Acute Treatment of Migraine
2004 Standout
Sex, Gender, and Pain: A Review of Recent Clinical and Experimental Findings
2009 Standout
Is the Placebo Powerless?
2001
Systematic review of the comorbidity of irritable bowel syndrome with other disorders: What are the causes and implications?
2002 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
The prevalence and characteristics of fibromyalgia in the general population
1995 Standout
Patient Adherence and Medical Treatment Outcomes
2002 Standout
The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease
2011 Standout
Pharmacological treatment of fibromyalgia
2011
The use of spirocyclic scaffolds in drug discovery
2014 Standout
How do you feel — now? The anterior insula and human awareness
2008 Standout
Ondansetron
1996
Augmented 5-HT Secretion in Pulmonary Neuroepithelial Bodies from PHD1 Null Mice
2015 StandoutNobel
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part II
2007 Standout
5-HT2A receptor subtype in the peripheral branch of sensory fibers is involved in the potentiation of inflammatory pain in rats
2002
Serotonin, tryptophan metabolism and the brain-gut-microbiome axis
2014 Standout
Effect of zopiclone on sleep quality, morning stiffness, widespread tenderness and pain and general discomfort in primary fibromyalgia patients. A double-blind randomized trial
1993
A Randomized Trial of Tai Chi for Fibromyalgia
2010 Standout
Placebo interventions for all clinical conditions
2004
Evidence-Based Knee Injections for the Management of Arthritis
2012
Biochemicals Associated With Pain and Inflammation are Elevated in Sites Near to and Remote From Active Myofascial Trigger Points
2008 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Osteoarthritis
2019 Standout
A Controlled Trial of Arthroscopic Surgery for Osteoarthritis of the Knee
2002 Standout
EULAR evidence-based recommendations for the management of fibromyalgia syndrome
2007
Enhancement of intestinal inflammation in mice lacking interleukin 10 by deletion of the serotonin reuptake transporter
2010
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Cystic Fibrosis Transmembrane Conductance Regulator Modulates Neurosecretory Function in Pulmonary Neuroendocrine Cell-Related Tumor Cell Line Models
2002
Cys-Loop Neuroreceptors: Structure to the Rescue?
2008
Extending the CONSORT Statement to Randomized Trials of Nonpharmacologic Treatment: Explanation and Elaboration
2008 Standout
Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals
2014 Standout
Pharmacological interventions for somatoform disorders in adults
2014 Standout
Diagnosis and Treatment of Hip and Knee Osteoarthritis
2021 Standout
Trigger Point Dry Needling
2006
Intestinal permeability – a new target for disease prevention and therapy
2014 Standout
The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study
1994 Standout
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
2016 Standout
The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America
2006 Standout
Chapter 4European guidelinesfor the management of chronicnonspecific low back pain
2006 Standout
Placebo interventions for all clinical conditions
2010
Heterocyclic Anticancer Compounds: Recent Advances and the Paradigm Shift towards the Use of Nanomedicine’s Tool Box
2015 Standout
A Comprehensive Review of the Placebo Effect: Recent Advances and Current Thought
2007 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Biomedical Importance of Indoles
2013 Standout
Discovery and Development of α7 Nicotinic Acetylcholine Receptor Modulators
2011
Nicotine and serotonin in immune regulation and inflammatory processes: a perspective
2006
Osteoarthritis: an update with relevance for clinical practice
2011 Standout
Exercise in fibromyalgia and related inflammatory disorders: known effects and unknown chances.
2009
Quantifying Publication Bias in Meta-Analysis
2017 Standout
Prescribed drugs containing nitrogen heterocycles: an overview
2020 Standout
Works of T Stratz being referenced
[Blocking of S2 receptors--a new treatment principle in generalized tendomyopathy (fibromyalgia)?].
1991
Beeinflusst die Depressivität den Behandlungseffekt von Tropisetron bei Fibromyalgiepatienten?
2003
Lokalbehandlung rheumatischer Erkrankungen mit dem 5-HT3-Rezeptor-Antagonisten Tropisetron
2003
Efficacy and tolerability of intravenous tropisetron in the treatment of fibromyalgia
2004
5-HT3-Rezeptor-Antagonisten als Analgetika bei rheumatischen Erkrankungen
2006
The influence of the 5‐HT3receptor antagonist tropisetron on pain in fibromyalgia: a functional magnetic resonance imaging pilot study
2004
The classification of fibromyalgia syndrome
2007
Local treatment of tendinopathies and myofascial painsyndromes with the 5‐HT3receptor antagonist tropisetron
2004
Vergleichende Untersuchungen über Häufigkeit, Geschlechts- und Altersverteilung bei generalisierter Tendomyopathie (GTM) und chronischem Lumbalsyndrom
1992
Wirksamkeit der Akupunktur bei Patienten mit generalisierter Tendomyopathie (Fibromyalgie)
1993
Fibromyalgia treatment with intravenous tropisetron administration.
2001
[Intramuscular etofenamate in the treatment of acute lumbago. Effectiveness and tolerance in comparison with intramuscular diclofenac-Na].
1990
[Comparative studies of the incidence of vegetative and functional disorders in backache and generalized tendomyopathies].
1992
Pathogenetic aspects of responsiveness to ondansetron (5-hydroxytryptamine type 3 receptor antagonist) in patients with primary fibromyalgia syndrome--a preliminary study.
1996
Expression of 5‐HT3Areceptors in cells of the immune system
2004
Intra‐articular treatment of arthritides and activated osteoarthritis with the 5‐HT3receptor antagonist tropisetron. A double‐blind study compared with methylprednisolone
2004
Antiinflammatory effects of 5‐HT3receptor antagonists in lipopolysaccharide‐stimulated primary human monocytes
2004
[Therapy of generalized tendomyopathy (fibromyalgia) caused by blocking 5-HT3 receptors].
1995